Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $113.7300 (-1.46%) ($112.9100 - $114.8300) on Mon. Jun. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.84% (three month average) | RSI | 45 | Latest Price | $113.7300(-1.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | UTHR declines -2% a day on average for past five trading days. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(36%) IBB(31%) VFMO(30%) VYM(30%) XBI(30%) | Factors Impacting UTHR price | UTHR will decline at least -1.42% in a week (0% probabilities). VIXM(-21%) VXX(-16%) UUP(-11%) XLC(-6%) TLT(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.42% (StdDev 2.84%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
Resistance Level | $119.76 | 5 Day Moving Average | $118.57(-4.08%) | 10 Day Moving Average | $121.14(-6.12%) | 20 Day Moving Average | $119.76(-5.04%) | To recent high | -9.6% | To recent low | 43.3% | Market Cap | $5.045b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |